A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa
Brief description of study
The purpose of this study is to determine if the research drug, sonelokimab, is effective in reducing the signs and symptoms of HS in people with moderate to severe disease, compared to placebo. Procedures include Vital signs, Physical Exam, Medical History, Blood and Urine tests, EKG and electronic questionnaires.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
